@article{article, title  = {{Cost-effectiveness analysis of rFVIIIFc versus contemporary rFVIII treatments for patients with severe hemophilia A without inhibitors in the United States}},

 publisher = {{Springer Nature}},

 url = {{}},

 year = {{2021}},

 month = {{7}},

 author = {{Bullement A and Knowles ES and DasMahapatra P and Ali T and Preblick R}},

 doi = {{10.1007/s41669-021-00283-6}},

 journal = {{PharmacoEconomics - Open}},

 note = {{Accessed on 2025/04/04}}}